心肺バイパス装置市場：製品、用途、エンドユーザー別-2024～2030年の世界予測

心肺バイパス装置市場規模は2023年に3億691万米ドルと推定され、2024年には3億1,992万米ドルに達し、CAGR 4.38%で2030年には4億1,451万米ドルに達すると予測されています。

心肺バイパス装置は、心肺バイパス（CPB）手技の中心であり、心臓手術中に一時的に心臓と肺の機能を担うように設計された高度なアセンブリを包含します。この装置には、心肺バイパス装置、血液輸送用チューブ、血液を酸素で濃縮し二酸化炭素を除去する酸素供給装置、その他熱交換器、フィルター、リザーバーなど様々な部品が含まれます。その主な目的は、循環と呼吸の安定を維持し、外科医が無血野で静止した心臓を手術できるようにし、手術の可視性と有効性を向上させることです。心肺バイパス装置は、血流、温度、ガス交換を正確に制御することにより、複雑な心臓手術の成功に極めて重要な役割を果たします。外科的介入を必要とする心臓疾患の罹患率上昇に伴う老年人口の増加が、市場拡大に寄与しています。しかし、CPB装置や手術のコストが高いため、特にヘルスケアシステムが進んでいない地域では市場の成長が制限される可能性があります。とはいえ、低侵襲手術の進歩や、CPB手技中のモニタリングや予測分析のための人工知能の統合は、この分野での大きな成長機会となることが期待されます。

製品：手技全体の安全性と有効性を高める酸素供給装置の使用が急増

自動輸血システムは、外科手術中および手術後に患者の血液を採取、処理、再注入するために設計されています。この技術は、大量出血が予想される手術において不可欠であり、ドナー輸血への依存を減らし、血液感染や反応のリスクを低減します。自動輸血システムは、患者がドナーの血液にさらされるのを最小限にするよう進化しており、安全性に関する大きな懸念に対処しています。心肺バイパス装置は心臓手術に不可欠であり、患者の体外で血液を酸素化し循環させることにより、循環および呼吸をサポートします。この機械は、冠動脈バイパス移植術（CABG）など、心臓の一時的な停止を必要とする手術に不可欠です。心肺バイパス装置は、特にAI技術の統合によって、コントロールと患者の転帰を向上させるための技術革新が続いています。酸素供給器は、心臓手術中に肺からガス交換の機能を引き継ぎ、心肺バイパス装置において重要な役割を果たします。患者の肺が使用されていない間も、血液の酸素化を確実に維持するために不可欠です。酸素吸入器は、より優れたガス交換機能と最小限の合併症で開発されており、手術全体の安全性と有効性を高めています。

エンドユーザー：透析センターによる心肺バイパス装置の高い使用率

透析センターでは、一時的な血液濾過を必要とする治療が中心であり、シンプルで効率的、かつ信頼性の高い機器が優先されます。ここでのニーズは、腎透析特有の要件をサポートする機器であり、多くの場合、体液バランスと電解質レベルの簡単なモニタリングと管理を容易にする機能が統合されています。病院は、心臓手術のような血液循環のサポートを必要とする幅広い外科手術を行うことから、心肺バイパス装置の最も広範な消費者層を形成しています。病院は、複雑さの異なる様々な方法に対応できる汎用性の高い大容量の装置を必要としています。また、シームレスな統合のためには、病院情報システムとの互換性も必要です。心臓治療を含む専門クリニックは、心肺バイパス装置の新興市場です。これらのクリニックでは一般的に緊急性のない手術や治療が行われるため、コンパクトで使いやすく、費用対効果の高い機器が必要とされます。特定の手術ニーズや患者集団に対応する機器が注目されています。

地域別インサイト

アメリカの心肺バイパス装置市場は、同地域における技術の進歩と心臓手術の増加に牽引され、力強い成長を示しています。米国がこの市場をリードしているのは、先進的なヘルスケアインフラ、高い医療費、主要市場プレイヤーの強い存在感によるものです。さらに、心血管疾患とその治療法に関する意識の高まりが、市場の成長をさらに後押ししています。欧州は心肺バイパス装置の重要な市場であり、確立されたヘルスケアシステムと人口の間で増加する心血管疾患の有病率に支えられています。欧州諸国は、より良い結果をもたらし、手術時間を短縮するバイパス装置の革新のための研究開発に多額の投資を行っています。中東およびアフリカでは、他の地域よりもペースは遅いもの、心肺バイパス装置に対する需要が伸びています。中東・アフリカでは、主にヘルスケア施設が徐々に充実し、医療へのアクセスが増加していることが市場成長の原動力となっています。同地域では、特に湾岸諸国において、ヘルスケア・インフラを強化するための国際的な協力や投資が行われています。アジア太平洋地域は、心肺バイパス装置のダイナミックな成長市場として浮上しています。特に中国やインドなどの国々では、医療費の増加、心血管疾患の有病率の増加、医療インフラの改善などの要因が市場成長を後押ししています。さらに、ヘルスケア改革への注目の高まりや政府の積極的な取り組みが、この地域の市場展望を高めています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは心肺バイパス装置市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、心肺バイパス装置市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.心肺バイパス装置市場の市場規模および予測は？

2.心肺バイパス装置市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.心肺バイパス装置市場の技術動向と規制枠組みは？

4.心肺バイパス装置市場における主要ベンダーの市場シェアは？

5.心肺バイパス装置市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に心血管疾患の罹患率が上昇
    • 低侵襲手術の需要増加
    • ヘルスケア費の増加とヘルスケアインフラ改善に向けた政府の取り組み
  • 抑制要因
    • 心肺バイパス装置に関連する高コスト
  • 機会
    • 監視と予測分析のための人工知能の統合
    • 革新的でコスト効率の高い製品の研究開発に向けた継続的な注力
  • 課題
    • 製品承認のための厳格な規制要件
• 市場セグメンテーション分析
  • 製品：全体的な手順の安全性と有効性を高めるため、酸素化装置の使用が急増
  • エンドユーザー：透析センターによる心肺バイパス装置の使用率が高い
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 心肺バイパス装置市場：製品別

• 自己輸血システム
• 心肺装置
• 酸素供給装置

第7章 心肺バイパス装置市場：用途別

• 心臓血管
• 血液透析
• 呼吸器

第8章 心肺バイパス装置市場：エンドユーザー別

• 透析センター
• 病院
• 専門クリニック

第9章 南北アメリカの心肺バイパス装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心肺バイパス装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心肺バイパス装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析（2023年）
• FPNVポジショニングマトリックス（2023年）
• 競合シナリオ分析
  • Inspira、心肺バイパス装置の新製品を発表
  • Inspira Technologiesは、血液を酸素で飽和させ、二酸化炭素を除去する独自の技術であるVORTX血液酸素化装置を開発
  • LivaNova、心肺バイパス手術用エッセンツ心肺バイパス装置で米国FDA 510（k）認可を取得
• 戦略分析と提言

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CARDIOPULMONARY BYPASS EQUIPMENT MARKET DYNAMICS
• FIGURE 7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEART-LUNG MACHINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEART-LUNG MACHINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY OXYGENATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY RESPIRATORY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 51. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 52. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 53. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 56. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 86. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 87. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 90. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 91. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 92. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 93. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 195. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 196. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 197. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 219. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 220. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 221. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 224. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 225. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 226. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 227. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 230. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 285. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

[191 Pages Report] The Cardiopulmonary Bypass Equipment Market size was estimated at USD 306.91 million in 2023 and expected to reach USD 319.92 million in 2024, at a CAGR 4.38% to reach USD 414.51 million by 2030.

Cardiopulmonary bypass equipment, central to cardiopulmonary bypass (CPB) procedures, encompasses a sophisticated assembly designed to temporarily assume the functions of the heart and lungs during cardiac surgery. This arrangement includes a heart-lung machine, tubing for blood transport, an oxygenator to enrich the blood with oxygen and remove carbon dioxide, and various other components such as heat exchangers, filters, and reservoirs. Its primary aim is to maintain circulatory and respiratory stability, enabling surgeons to operate on a still heart in a bloodless field, thus improving surgical visibility and efficacy. Cardiopulmonary bypass equipment plays a pivotal role in the successful outcome of complex cardiac surgeries by precisely controlling blood flow, temperature, and gas exchange. An increase in the geriatric population with rising incidence of cardiac conditions necessitating surgical intervention contributes to market expansion. However, the high cost of CPB devices and surgery can limit market growth, especially in regions with less advanced healthcare systems. Nevertheless, advancements in minimally invasive surgeries and the integration of artificial intelligence for monitoring and predictive analysis during CPB procedures are expected to be significant growth opportunities within the sector.

Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness

Autotransfusion systems are designed for collecting, processing, and reinfusion of a patient's blood during and after a surgical procedure. This technique is essential in surgeries where significant blood loss is anticipated, reducing the dependency on donor blood transfusions and thus lowering the risks of bloodborne infections and reactions. Autotransfusion systems have evolved to minimize patient exposure to donor blood, addressing major safety concerns. Heart-lung machines are critical for cardiac surgeries, providing circulatory and respiratory support by oxygenating and circulating blood outside the patient's body. This machine is indispensable for procedures requiring the temporary cessation of the heart, such as coronary artery bypass grafting (CABG). Heart-lung machines continue to see innovations to enhance control and patient outcomes, particularly with the integration of AI technologies. Oxygenators play a crucial role in cardiopulmonary bypass equipment, taking over the function of gas exchange from the lungs during cardiac surgeries. They are essential in ensuring the blood remains oxygenated while the patient's lungs are not in use. Oxygenators are being developed with better gas exchange capabilities and minimized complications, enhancing overall procedure safety and effectiveness.

End-User: High usage of cardiopulmonary bypass equipment by dialysis centers

Dialysis centers primarily focus on treatments that require temporary blood filtration, making simple, efficient, and reliable machines a priority. The need here is for equipment that supports the specific requirements of renal dialysis, often integrating features that facilitate easy monitoring and management of fluid balance and electrolyte levels. Hospitals form the most extensive consumer base for cardiopulmonary bypass equipment, given their broad range of surgical procedures that require blood circulation support, such as cardiac surgeries. Hospitals need versatile, high-capacity machines capable of supporting various methods with different complexity levels. Equipment should also be compatible with hospital information systems for seamless integration. Specialty clinics, including those focusing on cardiac care, represent an emerging market for cardiopulmonary bypass equipment. These clinics generally deal with non-emergency surgeries and treatments, necessitating compact, easy-to-use, and cost-effective equipment. The focus is on devices catering to specific surgical needs or patient populations.

Regional Insights

The American market for cardiopulmonary bypass equipment is showing robust growth, driven by technological advancements and increasing cardiac surgeries in the region. The United States leads this market due to its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key market players. Moreover, increasing awareness about cardiovascular diseases and their treatment options further fuels market growth. Europe is a significant market for cardiopulmonary bypass equipment, supported by its well-established healthcare system and the growing prevalence of cardiovascular diseases among its population. Countries in Europe are investing largely in research and development to innovate bypass machines that offer better outcomes and reduce surgery durations. Middle East and Africa exhibit a growing demand for cardiopulmonary bypass equipment, although at a slower pace than other areas. In the Middle East and Africa, the market growth is primarily driven by the gradual enhancement of healthcare facilities and increasing access to healthcare. The region sees international collaborations and investments, particularly in the Gulf countries, to bolster healthcare infrastructure. The APAC region is emerging as a dynamically growing market for cardiopulmonary bypass equipment. Factors including increasing healthcare expenditure, the growing prevalence of cardiovascular diseases, and improving healthcare infrastructure, particularly in countries like China and India, propel the market growth. Additionally, the rising focus on healthcare reforms and favorable government initiatives are enhancing market prospects in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiopulmonary Bypass Equipment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiopulmonary Bypass Equipment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Bypass Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Limited, Chalice Medical Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, Johnson & Johnson Services, Inc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., ProCell Surgical Inc., Senko Medical Instrument Manufacturing Co.,Ltd., Sorin Group, Stryker Corporation, Technowood Corporation, Teleflex Incorporated, Terumo Group, Xenios AG, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Bypass Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Autotransfusion Systems
  • Heart-Lung Machines
  • Oxygenators

• Application
  • Cardiovascular
  • Hemodialysis
  • Respiratory

• End-User
  • Dialysis Centers
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiopulmonary Bypass Equipment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiopulmonary Bypass Equipment Market?

3. What are the technology trends and regulatory frameworks in the Cardiopulmonary Bypass Equipment Market?

4. What is the market share of the leading vendors in the Cardiopulmonary Bypass Equipment Market?

5. Which modes and strategic moves are suitable for entering the Cardiopulmonary Bypass Equipment Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular diseases globally
    • 5.1.1.2. Increasing demand for minimally invasive surgical procedures
    • 5.1.1.3. Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with cardiopulmonary bypass equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence for monitoring and predictive analysis
    • 5.1.3.2. Ongoing focus on research and development to develop innovative and cost-effective products
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for product approval
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness
  • 5.2.2. End-User: High usage of cardiopulmonary bypass equipment by dialysis centers
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cardiopulmonary Bypass Equipment Market, by Product

• 6.1. Introduction
• 6.2. Autotransfusion Systems
• 6.3. Heart-Lung Machines
• 6.4. Oxygenators

7. Cardiopulmonary Bypass Equipment Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular
• 7.3. Hemodialysis
• 7.4. Respiratory

8. Cardiopulmonary Bypass Equipment Market, by End-User

• 8.1. Introduction
• 8.2. Dialysis Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Cardiopulmonary Bypass Equipment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiopulmonary Bypass Equipment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Bypass Equipment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Inspira To Unveil New Line of Cardio-Pulmonary Bypass Devices
  • 12.3.2. Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
  • 12.3.3. LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio